InvestorsHub Logo
icon url

redwing992006

12/04/19 8:37 AM

#277398 RE: youssef #277397

good news? can you post it
icon url

BooDog

12/04/19 9:02 AM

#277415 RE: youssef #277397

So maybe multiply the first partnership by 3 for the brilacidin-OM partnership?

That'd be cool if it happens!

I call these PR's bumper shots. Like in a TV show or a movie where they waste time showing someone riding a bike or in a car doing nada.

Hey! They're still alive! Maybe Locust Walk is coming through for us soon!

https://www.ipharminc.com/new-blog/2019/12/4/coverage-indicates-3x-greater-revenue-potential-for-brilacidin-oral-rinse

icon url

loanranger

12/04/19 9:19 AM

#277427 RE: youssef #277397

Thanks. It would be interesting to know if Credit Suisse concurs with any of IPIX's assertions.
If you have a Schwab account you can read a lot more about their assessment of Galera and their drugs. They initiated coverage at Neutral, btw.

See "GRTX: Initiate at Neutral: Compelling clinical data, challenging commercialization path" in the Rating's Summary section of the GTRX quote page.